Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of GILD will rise by +6.49% over the next 2 Weeks and hit $142.19 by Monday, May 25, 2026. In that time frame, GILD's share price is expected to range between $137.30 and $147.21.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 25, 2026 | 137.30 | 142.19 | 147.21 |
| May 22, 2026 | 135.06 | 139.23 | 143.44 |
| May 21, 2026 | 137.65 | 141.14 | 144.55 |
| May 20, 2026 | 137.70 | 140.58 | 143.58 |
| May 19, 2026 | 137.24 | 139.68 | 142.04 |
| May 18, 2026 | 135.96 | 138.04 | 140.19 |
| May 15, 2026 | 133.28 | 135.09 | 136.69 |
| May 14, 2026 | 135.40 | 137.00 | 138.52 |
| May 13, 2026 | 134.98 | 136.43 | 137.83 |
| May 12, 2026 | 134.28 | 135.54 | 136.88 |
GILD shares rose +2.51% in Tuesday, May 12, 2026's trading session, rising from a previous close of $133.52 to move at $136.86. The stock demonstrated notable intraday movement (see GILD's key stats for a full breakdown), fluctuating between $132.72 and $137.18, a +3.36% trading range. While recent weeks have seen some volatility, GILD has managed to secure a +7.13% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 5.36M shares changing hands, 4.49M fewer than the previous session. This amounted to $733.58M in total market activity.
Will GILD Continue Its Upward Trend?
According to analyst ratings and projections for GILD, Gilead Sciences, Inc. shares are anticipated to increase by +7.02%, potentially reaching $147.21 per share by May 25, 2026. Short-term technical indicators currently suggest a neutral sentiment for GILD. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the GILD stock forecast, now is a good time to buy GILD stock because its current trading price is -3.74% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on GILD covering social and institutional perspectives.
GILD Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into GILD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 51.34% to 59.36%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 51.06%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.56%, maintains a neutral outlook for the long term. Insights into GILD's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Gilead Sciences Short-Term Forecasts
GILD Forecast For Next 5 Days
Our algorithm anticipates Gilead Sciences (GILD) stock could hit $131.54 by May 19, 2026. This represents a -3.89% rise from today's price, following a +1.26% change over the past five days.
GILD Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Gilead Sciences, Inc. (GILD) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $128.23, which would mean a -6.31% decrease from the current price of $136.86. Projections for this period range from a high of $138.52 to a low of $119.64.
GILD Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Gilead Sciences's price over the next three months point to a rise. GILD stock is expected to peak at $147.52 on Jul 08, 2026 after potentially dipping to $127.30 on May 15, 2026. On average, GILD is likely to trade around $138.70 in the coming 90 days.
Gilead Sciences Stock Forecast 2025
Based on our predictive models, Gilead Sciences (GILD) is expected to trade between $127.30 and $155.87 throughout 2026. This would result in an average price of $142.36, potentially offering investors a +4.02% return from current levels.
Gilead Sciences, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Gilead Sciences, Inc. (GILD) is positioned to show a strong performance in May 2026. The price is predicted to move between $127.30 and $139.93, settling at an average of $133.63. This could translate to a -2.36% loss.
June 2026
Based on current market signals, Gilead Sciences, Inc. is projected to trend june 2026. We forecast a trading range from $131.37 to $145.12, with a likely average price of $138.85. Investors could expect a potential return of +1.45%.
July 2026
Our predictive algorithms indicate Gilead Sciences, Inc. stock may see a shift in July 2026. The expected range spans $134.14–$147.52, with an average target of $140.97. This represents a positive outlook and a possible gain of +3.00%.
August 2026
Analyzing established trends, Gilead Sciences, Inc. looks set to move in August 2026. Projections place the stock between $134.40 and $146.69, averaging around $140.91. This suggests a +2.96% gain from current levels.
September 2026
Market indicators suggest Gilead Sciences, Inc. could experience notable changes during September 2026. Prices could fluctuate within $136.09 to $146.74, with a midpoint forecast of $141.44. The stock might deliver a +3.34% gain.
October 2026
Forecasting for October 2026, models estimate that Gilead Sciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $132.61 and $149.76, averaging $142.22. This signals a positive trajectory with potential returns around +3.91%.
November 2026
According to our latest forecast models, Gilead Sciences, Inc. (GILD) is positioned to show a strong performance in November 2026. The price is predicted to move between $141.32 and $154.42, settling at an average of $148.14. This could translate to a +8.24% gain.
December 2026
Based on current market signals, Gilead Sciences, Inc. is projected to trend december 2026. We forecast a trading range from $142.69 to $155.87, with a likely average price of $149.52. Investors could expect a potential return of +9.25%.
January 2027
Our predictive algorithms indicate Gilead Sciences, Inc. stock may see a shift in January 2027. The expected range spans $144.07–$155.17, with an average target of $149.81. This represents a positive outlook and a possible gain of +9.46%.
February 2027
Analyzing established trends, Gilead Sciences, Inc. looks set to move in February 2027. Projections place the stock between $144.71 and $155.98, averaging around $150.12. This suggests a +9.68% gain from current levels.
March 2027
Market indicators suggest Gilead Sciences, Inc. could experience notable changes during March 2027. Prices could fluctuate within $143.87 to $159.68, with a midpoint forecast of $151.26. The stock might deliver a +10.52% gain.
April 2027
Forecasting for April 2027, models estimate that Gilead Sciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $150.72 and $163.65, averaging $157.01. This signals a positive trajectory with potential returns around +14.72%.
May 2027
According to our latest forecast models, Gilead Sciences, Inc. (GILD) is positioned to show a strong performance in May 2027. The price is predicted to move between $153.51 and $164.21, settling at an average of $159.24. This could translate to a +16.35% gain.
GILD's history of dividends and stock splits also plays a role in long-term investor confidence.

